Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.
Aliment Pharmacol Ther
; 54(3): 234-248, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34114667
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biological Products
/
Inflammatory Bowel Diseases
/
Colitis, Ulcerative
/
Crohn Disease
Type of study:
Health_economic_evaluation
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom